New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma
暂无分享,去创建一个
Shin-ya Ogata | S. Shiono | Toru Sato | N. Yanagawa | M. Abiko | S. Ogata | G. Tamura | Naoki Yanagawa | Satoshi Shiono | Masami Abiko | Toru Sato | Gen Tamura | Shin‐ya Ogata
[1] Kenji Suzuki,et al. Grade of Stromal Invasion in Small Adenocarcinoma of the Lung: Histopathological Minimal Invasion and Prognosis , 2004, The American journal of surgical pathology.
[2] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[3] Akihiko Yoshizawa,et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.
[4] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[5] Akihiko Yoshizawa,et al. A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.
[6] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[7] R. Rami-Porta,et al. The New Tumor, Node, and Metastasis Staging System , 2011, Seminars in respiratory and critical care medicine.
[8] B. Stewart,et al. World Cancer Report , 2003 .
[9] P. Boyle,et al. World Cancer Report 2008 , 2009 .
[10] Michael Thomas,et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] Zoe Wainer,et al. Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[13] W. Gerald,et al. Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis , 2008, The American journal of surgical pathology.
[14] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[15] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[16] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.